Clinical and molecular characterization of novel FARS2 variants causing neonatal mitochondrial disease.


Journal

Molecular genetics and metabolism
ISSN: 1096-7206
Titre abrégé: Mol Genet Metab
Pays: United States
ID NLM: 9805456

Informations de publication

Date de publication:
11 2023
Historique:
received: 14 06 2023
revised: 22 07 2023
accepted: 22 07 2023
medline: 14 11 2023
pubmed: 1 8 2023
entrez: 31 7 2023
Statut: ppublish

Résumé

FARS2 encodes the mitochondrial phenylalanyl-tRNA synthetase (mtPheRS), which is essential for charging mitochondrial (mt-) tRNA

Identifiants

pubmed: 37523899
pii: S1096-7192(23)00287-1
doi: 10.1016/j.ymgme.2023.107657
pii:
doi:

Substances chimiques

FARS2 protein, human EC 6.1.1.20
Mitochondrial Proteins 0
Phenylalanine-tRNA Ligase EC 6.1.1.20
RNA, Transfer 9014-25-9
RNA, Transfer, Phe 0

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107657

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM125908
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to disclose.

Auteurs

Wenqian Chen (W)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.

Preeya Rehsi (P)

Metabolic Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Kyle Thompson (K)

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE2 4HH, UK.

Mildrid Yeo (M)

Metabolic Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Karen Stals (K)

Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.

Langping He (L)

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE2 4HH, UK; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne NE1 4LP, UK.

Paul Schimmel (P)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA; The Scripps Florida Research Institute at the University of Florida, Jupiter, FL 33458, USA.

Zofia M A Chrzanowska-Lightowlers (ZMA)

Wellcome Centre for Mitochondrial Research, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE2 4HH, UK.

Emma Wakeling (E)

North East Thames Regional Genetic Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.

Robert W Taylor (RW)

Wellcome Centre for Mitochondrial Research, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne NE2 4HH, UK; NHS Highly Specialised Service for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne NE1 4LP, UK. Electronic address: robert.taylor@ncl.ac.uk.

Bernhard Kuhle (B)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen 37073, Germany. Electronic address: bernhard.kuhle@med.uni-goettingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH